D-1071-2014 Class III Terminated

Recalled by PACK Pharmaceuticals, LLC — Buffalo Grove, IL

FDA drug recall D-1071-2014 was initiated by PACK Pharmaceuticals, LLC on September 9, 2013 and is designated Class III. Reason for recall: Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the … The recall status is terminated (terminated April 11, 2014). Affected quantity: 78 bottles.

Recall Details

Product Type
Drugs
Report Date
February 12, 2014
Initiation Date
September 9, 2013
Termination Date
April 11, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
78 bottles

Product Description

Timolol Maleate Sterile Ophthalmic Solution, USP 0.25%, 10mL, (NDC 16571-140-10). The products are packaged in Low Density Polyethylene (LDPE) Blow Fill Seal containers equipped with a dropper tip. The filled bottles are individually packaged into fiberboard cartons.

Reason for Recall

Defective Container: Stability samples of both products were noted to have some white solid product residue, identified as dried active ingredients along with the preservative, on the exterior of the bottles.

Distribution Pattern

Nationwide and Puerto Rico.

Code Information

Lot #:NW3071. Exp. 06/15.